FDA-Drug2026-05-27Class IPROCESSING DEFECT
MG217 Multi-Symptom Treatment Cream recalled for Staphylococcus aureus contamination
MOLDNationwide distribution
MG217 skin cream recalled for bacterial contamination
Wisconsin Pharmacal Company's MG217 Multi-Symptom Treatment Cream (colloidal oatmeal 2%, 6 oz) has been found to contain Staphylococcus aureus bacteria. The contamination was confirmed in lot #1024088 (expiration 11/30/2026). About 690 tubes were distributed nationwide and to the Bahamas.
- Stop using this product if you have it at home.
- Check your MG217 cream for lot #1024088.
- Contact your pharmacist or doctor if you have used this product and have any skin irritation or signs of infection.
Hazard
Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.
Sold states
USA Nationwide and Bahamas
Affected count
690 tubes
Manufactured in
N168w22223 Main St, Jackson, WI, United States
Products
MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0553-2026Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief